Shenzhen YHLO Biotech Co (SHSE:688575) Market Cap: ¥5,125 Mil (As of Jul. 07, 2026)


SHSE:688575 Shenzhen YHLO Biotech Co Ltd SHSE:688575
64 GF Score
Price ¥8.97
GF Value ¥14.51
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is Shenzhen YHLO Biotech Co Market Cap?

Shenzhen YHLO Biotech Co SHSE:688575 -3.03% 64 Market Cap is ¥5,125 Mil as of Jul. 07, 2026. GuruFocus rates SHSE:688575 with a GF Score™ of 64/100 and a GF Value™ of ¥14.51 (Significantly Undervalued). The stock has 7 warning signs investors should review. Among 868 Medical Devices & Instruments companies, Shenzhen YHLO Biotech Co ranks better than 75.12% on this metric.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Shenzhen YHLO Biotech Co's share price for the quarter that ended in Mar. 2026 was ¥14.62. Shenzhen YHLO Biotech Co's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 571 Mil. Therefore, Shenzhen YHLO Biotech Co's market cap for the quarter that ended in Mar. 2026 was ¥8,354 Mil.

Shenzhen YHLO Biotech Co's quarterly market cap declined from Sep. 2025 (¥8,314 Mil) to Dec. 2025 (¥8,114 Mil) but then increased from Dec. 2025 (¥8,114 Mil) to Mar. 2026 (¥8,354 Mil).

Shenzhen YHLO Biotech Co's annual market cap declined from Dec. 2023 (¥12,993 Mil) to Dec. 2024 (¥9,010 Mil) and declined from Dec. 2024 (¥9,010 Mil) to Dec. 2025 (¥8,114 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Shenzhen YHLO Biotech Co's Enterprise Value for Today is ¥5,552 Mil.


Shenzhen YHLO Biotech Co  (SHSE:688575) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Shenzhen YHLO Biotech Co Market Cap Related Terms


Shenzhen YHLO Biotech Co Market Cap Historical Data

* Premium members only.

The historical data trend for Shenzhen YHLO Biotech Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shenzhen YHLO Biotech Co Market Cap Chart

Shenzhen YHLO Biotech Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Market Cap
Get a 7-Day Free Trial Premium Member Only 13,992.75 11,141.55 12,993.11 9,010.22 8,113.71

Shenzhen YHLO Biotech Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9,206.69 8,322.53 8,313.70 8,113.71 8,353.69

SHSE:688575 vs ABT, SYK, MDT: Market Cap Comparison

For the Medical Devices subindustry, Shenzhen YHLO Biotech Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shenzhen YHLO Biotech Co Market Cap vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shenzhen YHLO Biotech Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Shenzhen YHLO Biotech Co's Market Cap falls into.


SHSE:688575
64GF Score
Shenzhen YHLO Biotech Co Ltd SHSE:688575
Market Cap is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shenzhen YHLO Biotech Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Shenzhen YHLO Biotech Co's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as

Market Cap (A: Dec. 2025 )=Share Price (A: Dec. 2025 )*Shares Outstanding (EOP) (A: Dec. 2025 )
=¥14.2*571.388
=¥8,114

Shenzhen YHLO Biotech Co's Market Cap for the quarter that ended in Mar. 2026 is calculated as

Market Cap (Q: Mar. 2026 )=Share Price (Q: Mar. 2026 )*Shares Outstanding (EOP) (Q: Mar. 2026 )
=¥14.62*571.388
=¥8,354

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of ¥5,125 Mil mean?
Shenzhen YHLO Biotech Co (SHSE:688575) has a Market Cap of ¥5,125 Mil as of Jul. 07, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Shenzhen YHLO Biotech Co and its competitors. According to the industry distribution chart, Shenzhen YHLO Biotech Co ranks #216 out of 868 companies in the Medical Devices & Instruments industry, placing it in the top 24.9%.
Is Shenzhen YHLO Biotech Co's Market Cap too high?
Shenzhen YHLO Biotech Co's current Market Cap is ¥5,125 Mil. Based on the distribution chart, Shenzhen YHLO Biotech Co ranks #216 out of 868 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Shenzhen YHLO Biotech Co has a GF Score™ of 64/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shenzhen YHLO Biotech Co's Market Cap compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Shenzhen YHLO Biotech Co ranks #216 out of 868 companies for Market Cap. This places Shenzhen YHLO Biotech Co in the top 25% of its industry — outperforming the majority of peers. The industry median Market Cap is 121.35. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 121.35, based on 868 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Shenzhen YHLO Biotech Co and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 121.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shenzhen YHLO Biotech Co's current Market Cap is ¥5,125 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shenzhen YHLO Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Shenzhen YHLO Biotech Co (SHSE:688575) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥14.51, compared to a current price of ¥8.97 — trading 38.2% below its estimated fair value. The current Market Cap is ¥5,125 Mil. Shenzhen YHLO Biotech Co's overall GF Score™ is 64/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Shenzhen YHLO Biotech Co (SHSE:688575), the current Market Cap is ¥5,125 Mil as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shenzhen YHLO Biotech Co (SHSE:688575) Overvalued in 2026?

Based on GuruFocus' analysis, Shenzhen YHLO Biotech Co stock appears to be undervalued. The current stock price of ¥8.97 is trading 38.2% below its estimated GF Value™ of ¥14.51. GuruFocus considers Shenzhen YHLO Biotech Co to be Significantly Undervalued.

Key valuation signals for SHSE:688575:

  • Market Cap: ¥5,125 Mil
  • GF Value™: ¥14.51 vs. price of ¥8.97 (38.2% below fair value)
  • GF Score™: 64/100 with 7 warning signs

No single metric tells the full story. See the SHSE:688575 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shenzhen YHLO Biotech Co Business Description

Address Baolong 2nd Road, Baolong Street, Building 1, Yahuilong Biotechnology Factory Area, Longgang District, Guangdong Province, Shenzhen, CHN, 518116
Shenzhen YHLO Biotech Co Ltd is engaged in the research, development, production and sales of in vitro diagnostic instruments and supporting reagents based on chemiluminescence immunoassay. Its product portfolio includes solutions based on technologies such as chemiluminescence, biochemistry, indirect immunofluorescence, immunoblotting, fluorescent immunochromatography, and colloidal gold immunochromatography. Its products are used in diagnostic applications including autoimmunity, reproductive health, infection, liver disease, and respiratory disease testing, and are supplied to healthcare institutions and testing centers.
64GF Score

Get the complete analysis for SHSE:688575

Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥8.97
Price
¥14.51
GF Value